Skip to main content
SpringerLink
Log in

Closing Remarks: Current Position of Calcium Channel Antagonists in Hypertension — the Role of Manidipine

  • Conclusion
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995; 274: 620–5

    Article  PubMed  CAS  Google Scholar 

  2. Pahor M, Guralnik JM, Corti MC, et al. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995; 43: 1191–7

    PubMed  CAS  Google Scholar 

  3. Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326–31

    CAS  Google Scholar 

  4. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757–64

    CAS  Google Scholar 

  5. Liu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998; 16: 1823–9

    CAS  Google Scholar 

  6. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237–45

    Article  PubMed  CAS  Google Scholar 

  7. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755–62

    CAS  Google Scholar 

  8. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981–97

    Article  Google Scholar 

  9. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022–31

    Article  PubMed  CAS  Google Scholar 

  10. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527–35

    Article  PubMed  CAS  Google Scholar 

  11. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53

    Article  Google Scholar 

  12. Zanchetti A, Omboni S, La Commare P, et al. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001; 38: 642–50

    Article  PubMed  CAS  Google Scholar 

  13. Takabatake T, Ohta H, Sasaki T, et al. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients. Eur J Clin Pharmacol 1993; 45: 321–5

    CAS  Google Scholar 

  14. Martinez-Martin F, Saiz-Satjes M. Addition of manidipine in type 2 diabetic patients with uncontrolled hypertension and microalbuminuria: the AMANDHA Trial [Abstract]. J Hypertens 2004; 22 suppl. 2: 245

    Article  Google Scholar 

  15. Fogari R, Mugellini A, Zoppi A, et al. Effect of manidipine and lisinopril on albuminuria and ventricular mass in diabetic hypertensive patients with microalbuminuria [Abstract no. P0209]. J Hypertens 2002; 20 suppl. 4: 56

    Google Scholar 

  16. Bellinghieri G, Mazzaglia G, Savica V, et al. Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: a multicenter randomized controlled trial. Ren Fail 2003; 25: 681–9

    Article  PubMed  CAS  Google Scholar 

  17. Del Vecchio L, Pozzi M, Salvetti A, et al. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. J Nephrol 2004; 17: 261–9

    Google Scholar 

  18. Hayashi K, Ozawa Y, Fujiwara K, et al. Role of actions of calcium antagonists on efferent arterioles-with special references to glomerular hypertension. Am J Nephrol 2003; 23: 229–44

    Article  PubMed  CAS  Google Scholar 

  19. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–72

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro di Fisiologia Clinica e Ipertensione, Istituto Auxologico Italiano and Ospedale Maggiore di Milano, Via Francesco Sforza 35, 20122, Milan, Italy

    Alberto Zanchetti

Authors
  1. Alberto Zanchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alberto Zanchetti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zanchetti, A. Closing Remarks: Current Position of Calcium Channel Antagonists in Hypertension — the Role of Manidipine. Drugs 65 (Suppl 2), 40–42 (2005). https://doi.org/10.2165/00003495-200565002-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200565002-00006

Keywords

Search

Navigation